[Efficacy and Safety of Fecal Microbiota Transplantation and Prospect of Microbe-based Therapies for Inflammatory Bowel Disease].
Fecal microbiota transplantation
Inflammatory bowel diseases
Microbe-based therapies
Journal
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
ISSN: 2233-6869
Titre abrégé: Korean J Gastroenterol
Pays: Korea (South)
ID NLM: 101189416
Informations de publication
Date de publication:
25 07 2021
25 07 2021
Historique:
received:
10
06
2021
revised:
15
07
2021
accepted:
16
07
2021
entrez:
27
7
2021
pubmed:
28
7
2021
medline:
11
11
2021
Statut:
ppublish
Résumé
The use of 5-ASA, immunomodulators, biologics, and small molecule drugs are the main treatment for inflammatory bowel disease (IBD), however, fecal microbiota transplantation (FMT) is also drawing attention as a treatment to improve intestinal dysbiosis by transplantaing normal human stool into patients with IBD. FMT demonstrates relatively good effects in inducing clinical remission in IBD, but unlike
Identifiants
pubmed: 34312355
pii: kjg.2021.089
doi: 10.4166/kjg.2021.089
doi:
Types de publication
Journal Article
Review
Langues
kor
Sous-ensembles de citation
IM